ClinicalTrials.Veeva
Menu

Find clinical trials for Adenocarcinoma in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pancreatic Cancer
Colorectal Cancer
Non-Small-Cell Lung Carcinoma
Stomach Cancer
Esophageal Cancer
Cancer
Carcinoma

Adenocarcinoma trials near Birmingham, AL, USA:

ProAgio in Pancreatic Ductal Adenocarcinoma (PDAC)

nab-paclitaxel (G-nP) or gemcitabine, nab-paclitaxel (G-nP) and atezolizumab in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

and safety of AZD0901 compared to Investigator's choice of therapy as 2L+ treatment for participants with advanced or metastatic gastric or GEJ adenocarcinoma...

Enrolling
Gastroesophageal Junction Cancer
Gastric Cancer
Drug: Docetaxel
Drug: Irinotecan

Phase 3

AstraZeneca
AstraZeneca

Birmingham, Alabama, United States and 185 other locations

Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...

Enrolling
Esophageal Adenocarcinoma
Barretts Esophagus With Dysplasia
Diagnostic Test: Esophagogastroduodenoscopy
Device: EsoGuard (lab assay)
Lucid Diagnostics

Birmingham, Alabama, United States and 37 other locations

* To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advan...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Metastatic Colorectal Cancer
Drug: Cetuximab
Drug: ERAS-007

Phase 1, Phase 2

Erasca

Birmingham, Alabama, United States and 13 other locations

This is a randomized, phase 1b study to assess the safety, tolerability, pharmacokinetics (PK), and efficacy of sovilnesib at different dose levels t...

Active, not recruiting
High Grade Serous Adenocarcinoma of Ovary
Primary Peritoneal Carcinoma
Drug: Sovilnesib

Phase 1

Volastra Therapeutics

Birmingham, Alabama, United States and 12 other locations

This clinical trial is studying advanced solid tumors. Solid tumors are cancers that start in a part of your body like your lungs or liver instead of...

Enrolling
Pancreatic Adenocarcinoma
Endometrial
Drug: PF-08052666

Phase 1

Seagen, a wholly owned subsidiary of Pfizer

Birmingham, Alabama, United States and 31 other locations

IIMGN151-1001 is a Phase 1, first in human, open-label dose-escalation, optimization, and expansion study designed to characterize the safety, tolera...

Enrolling
High Grade Serous Adenocarcinoma of Ovary
Endometrial Cancer
Drug: IMGN151

Phase 1

AbbVie
AbbVie

Birmingham, Alabama, United States and 52 other locations

The main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally ad...

Enrolling
Pancreatic Ductal Adenocarcinoma
Advanced Solid Tumor
Drug: Pembrolizumab
Drug: Irinotecan

Phase 1

Lilly
Lilly

Birmingham, Alabama, United States and 57 other locations

This clinical trial is evaluating a drug called ART0380 in participants with advanced or metastatic solid tumors. The main goals of this study are to...

Enrolling
Pancreatic Ductal Adenocarcinoma
Endometrial Cancer
Drug: Irinotecan
Drug: ART0380

Phase 1, Phase 2

Artios Pharma

Birmingham, Alabama, United States and 71 other locations

and bevacizumab in participants who have newly diagnosed metastatic adenocarcinoma of the colon/rectum. The study will also evaluate if the ...

Active, not recruiting
Neuropathy
Metastatic Colorectal Carcinoma
Other: Placebo
Drug: BXQ-350

Phase 1, Phase 2

Bexion Pharmaceuticals

Birmingham, Alabama, United States and 11 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems